Alaunos Therapeutics (TCRT) Other Working Capital Changes (2009 - 2026)
Alaunos Therapeutics' (TCRT) quarterly Other Working Capital Changes came in at -$40000.0 in Q1 2026, down 128.57% YoY from $140000.0 in Q1 2025, and up 80.2% on a QoQ basis from -$202000.0 in Q4 2025.
Alaunos Therapeutics (TCRT) Other Working Capital Changes (2009 - 2026) Analysis & Trends
Alaunos Therapeutics (TCRT) has 2 years of Other Working Capital Changes data on file, last reported at -$500000.0 in Q4 2023.
- Quarterly Other Working Capital Changes fell 128.57% year-over-year to -$40000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$530000.0 (down 476.09% YoY) and the FY2025 annual result came in at -$350000.0, up 35.06% from the prior year.
- Other Working Capital Changes improved to -$40000.0 in Q1 2026, from -$202000.0 in the prior quarter.
- In the past five years, Other Working Capital Changes ranged from a high of $1.3 million in Q4 2023 to a low of -$501000.0 in Q3 2022.
- A 5-year average of -$23352.9 and a median of -$149000.0 in 2022 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes jumped 2646.0% — and 2024, when it plunged 526.53%.
- Tracing TCRT's Other Working Capital Changes over 5 years: stood at -$50000.0 in 2022, then jumped by 2646.0% to $1.3 million in 2023, then tumbled by 116.34% to -$208000.0 in 2024, then advanced by 2.88% to -$202000.0 in 2025, then jumped by 80.2% to -$40000.0 in 2026.
- The last three Other Working Capital Changes figures came in at -$500000.0 (Q4 2023), $500000.0 (Q3 2023), and -$146000.0 (Q1 2018), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40,000.00 |
| Mar 31, 2026 | -40,000.00 |
| Mar 31, 2026 | -40,000.00 |
| Dec 31, 2025 | -202,000.00 |
| Dec 31, 2025 | -202,000.00 |
| Dec 31, 2025 | -202,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Sep 30, 2025 | -166,000.00 |
| Jun 30, 2025 | -122,000.00 |
| Jun 30, 2025 | -122,000.00 |
| Jun 30, 2025 | -122,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Mar 31, 2025 | 140,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Dec 31, 2024 | -208,000.00 |
| Sep 30, 2024 | -344,000.00 |
| Sep 30, 2024 | -344,000.00 |